Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2
A Randomized, Double-Blind, Placebo-Controlled Evaluation of Bupropion vs Placebo for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated:  1/11/2017
Rancho Cucamonga Clinic
mi
from
Rancho Cucamonga, CA
Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2
A Randomized, Double-Blind, Placebo-Controlled Evaluation of Bupropion vs Placebo for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated: 1/11/2017
Rancho Cucamonga Clinic
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1
N-acetylcysteine as Treatment in Cocaine Addiction
Status: Enrolling
Updated:  1/11/2017
Medical University of South Carolina
mi
from
Charleston, SC
Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1
N-acetylcysteine as Treatment in Cocaine Addiction
Status: Enrolling
Updated: 1/11/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts
Serotonin Treatment of Cocaine Dependence
Status: Enrolling
Updated:  1/11/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts
Serotonin Treatment of Cocaine Dependence
Status: Enrolling
Updated: 1/11/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
Two Medications, Disulfiram and Naltrexone, in the Treatment of Patients With Both Cocaine and Alcohol Dependence
Status: Enrolling
Updated:  1/11/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
Two Medications, Disulfiram and Naltrexone, in the Treatment of Patients With Both Cocaine and Alcohol Dependence
Status: Enrolling
Updated: 1/11/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effectiveness of Bupropion in Treating Marijuana Dependent Individuals
Effects of Bupropion on Marijuana Withdrawal Symptoms
Status: Enrolling
Updated:  1/11/2017
McLean Hospital, Dept. of Psychiatry
mi
from
Belmont, MA
Effectiveness of Bupropion in Treating Marijuana Dependent Individuals
Effects of Bupropion on Marijuana Withdrawal Symptoms
Status: Enrolling
Updated: 1/11/2017
McLean Hospital, Dept. of Psychiatry
mi
from
Belmont, MA
Click here to add this to my saved trials
Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2
A Double-Blind, Placebo Controlled Trial of Propranolol and Amantadine for the Treatment of Cocaine Dependent Subjects With Severe Cocaine Withdrawal Symptoms
Status: Enrolling
Updated:  1/11/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2
A Double-Blind, Placebo Controlled Trial of Propranolol and Amantadine for the Treatment of Cocaine Dependent Subjects With Severe Cocaine Withdrawal Symptoms
Status: Enrolling
Updated: 1/11/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rivastigmine For Methamphetamine Dependent Individuals
Double-Blind Randomized Placebo Controlled Trial of Rivastigmine (Excelon) as a Potential Medication for Methamphetamine Abuse
Status: Enrolling
Updated:  1/11/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Rivastigmine For Methamphetamine Dependent Individuals
Double-Blind Randomized Placebo Controlled Trial of Rivastigmine (Excelon) as a Potential Medication for Methamphetamine Abuse
Status: Enrolling
Updated: 1/11/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1
LAAM With Behavioral Treatment for Opioid/Cocaine Abuse
Status: Enrolling
Updated:  1/11/2017
VA Connecticut Healthcare System
mi
from
West Haven, CT
The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1
LAAM With Behavioral Treatment for Opioid/Cocaine Abuse
Status: Enrolling
Updated: 1/11/2017
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users
Treatment of Acute Hepatitis C Virus Infection in Injection Drug Users With Pegylated Interferon for 24 Weeks
Status: Enrolling
Updated:  1/11/2017
Harborview Medical Center, 325 Ninth Ave 1EC32
mi
from
Seattle, WA
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users
Treatment of Acute Hepatitis C Virus Infection in Injection Drug Users With Pegylated Interferon for 24 Weeks
Status: Enrolling
Updated: 1/11/2017
Harborview Medical Center, 325 Ninth Ave 1EC32
mi
from
Seattle, WA
Click here to add this to my saved trials
Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals
Phase 1, Double-blind, Placebo-controlled Assessment of Interactions Between 2 Doses of Cocaine and Three Doses of Escalating Vanoxerine (GBR 12909) in Cocaine Using Volunteers
Status: Enrolling
Updated:  1/11/2017
University of Texas Health Science Center
mi
from
Houston, TX
Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals
Phase 1, Double-blind, Placebo-controlled Assessment of Interactions Between 2 Doses of Cocaine and Three Doses of Escalating Vanoxerine (GBR 12909) in Cocaine Using Volunteers
Status: Enrolling
Updated: 1/11/2017
University of Texas Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens
Opioid Maintenance: Optimum Stabilization and Withdrawal
Status: Enrolling
Updated:  1/11/2017
Department of Psychatiry, Mental Services
mi
from
Houston, TX
Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens
Opioid Maintenance: Optimum Stabilization and Withdrawal
Status: Enrolling
Updated: 1/11/2017
Department of Psychatiry, Mental Services
mi
from
Houston, TX
Click here to add this to my saved trials
Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1
Selegiline for Treatment of Cannabis Dependence
Status: Enrolling
Updated:  1/11/2017
MRU
mi
from
New Haven, CT
Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1
Selegiline for Treatment of Cannabis Dependence
Status: Enrolling
Updated: 1/11/2017
MRU
mi
from
New Haven, CT
Click here to add this to my saved trials
Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1
Naltrexone and Lofexidine in Detoxified Heroin Addicts
Status: Enrolling
Updated:  1/11/2017
Substance Abuse Treatment Unit
mi
from
New Haven, CT
Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1
Naltrexone and Lofexidine in Detoxified Heroin Addicts
Status: Enrolling
Updated: 1/11/2017
Substance Abuse Treatment Unit
mi
from
New Haven, CT
Click here to add this to my saved trials
Effectiveness of Self-Help for Dually-Diagnosed Persons - 1
Effectiveness of Self-Help for Dually-Diagnosed Persons
Status: Enrolling
Updated:  1/11/2017
Albert Einstein Dept of Psychiatry
mi
from
Bronx, NY
Effectiveness of Self-Help for Dually-Diagnosed Persons - 1
Effectiveness of Self-Help for Dually-Diagnosed Persons
Status: Enrolling
Updated: 1/11/2017
Albert Einstein Dept of Psychiatry
mi
from
Bronx, NY
Click here to add this to my saved trials
Integrated Treatment for Cocaine and Mood Disorders - 1
ERP-8654 - Integrated Treatment for Cocaine and Mood Disorders
Status: Enrolling
Updated:  1/11/2017
University of Texas Health Sci Cntr Houston
mi
from
Houston, TX
Integrated Treatment for Cocaine and Mood Disorders - 1
ERP-8654 - Integrated Treatment for Cocaine and Mood Disorders
Status: Enrolling
Updated: 1/11/2017
University of Texas Health Sci Cntr Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals
Marijuana Pharmacotherapies: Controlled Clinical Trials With Nefazodone and Bupropion
Status: Enrolling
Updated:  1/11/2017
New York State Psychiatric Institute
mi
from
New York, NY
Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals
Marijuana Pharmacotherapies: Controlled Clinical Trials With Nefazodone and Bupropion
Status: Enrolling
Updated: 1/11/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Vouchers vs. Prizes for Methadone Patients - 1
Vouchers vs. Prizes for Methadone Patients
Status: Enrolling
Updated:  1/11/2017
University of Connecticut Health Center
mi
from
Farmington, CT
Vouchers vs. Prizes for Methadone Patients - 1
Vouchers vs. Prizes for Methadone Patients
Status: Enrolling
Updated: 1/11/2017
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Contingency Management for Attendance - 2
Contingency Management for Attendance
Status: Enrolling
Updated:  1/11/2017
University of Connecticut Health Center
mi
from
Farmington, CT
Contingency Management for Attendance - 2
Contingency Management for Attendance
Status: Enrolling
Updated: 1/11/2017
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1
Phase 1, Double-Blind, Placebo-Controlled Multiple Dose Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine
Status: Enrolling
Updated:  1/11/2017
Uniformed Services University of Health Science
mi
from
Bethesda, MD
Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1
Phase 1, Double-Blind, Placebo-Controlled Multiple Dose Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine
Status: Enrolling
Updated: 1/11/2017
Uniformed Services University of Health Science
mi
from
Bethesda, MD
Click here to add this to my saved trials
Serotonin, Impulsivity, and Cocaine Dependence Treatment
Serotonin, Impulsivity, and Cocaine Dependence Treatment
Status: Enrolling
Updated:  1/11/2017
University of Texas Houston Health Science Center
mi
from
Houston, TX
Serotonin, Impulsivity, and Cocaine Dependence Treatment
Serotonin, Impulsivity, and Cocaine Dependence Treatment
Status: Enrolling
Updated: 1/11/2017
University of Texas Houston Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of Buspirone in Opiate Withdrawal
Effects of Buspirone in Withdrawal From Opiates
Status: Enrolling
Updated:  1/11/2017
VA New York Harbor Healthcare System - Brooklyn Campus
mi
from
Brooklyn, NY
Effects of Buspirone in Opiate Withdrawal
Effects of Buspirone in Withdrawal From Opiates
Status: Enrolling
Updated: 1/11/2017
VA New York Harbor Healthcare System - Brooklyn Campus
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Randomized Trial of the Positive Action Program in Hawaii Schools
The Positive Action Program: Outcomes and Mediators
Status: Enrolling
Updated:  1/11/2017
Positive Action, Inc.
mi
from
Twin Falls, ID
Randomized Trial of the Positive Action Program in Hawaii Schools
The Positive Action Program: Outcomes and Mediators
Status: Enrolling
Updated: 1/11/2017
Positive Action, Inc.
mi
from
Twin Falls, ID
Click here to add this to my saved trials
Randomized Trial of the Positive Action Program in Hawaii Schools
The Positive Action Program: Outcomes and Mediators
Status: Enrolling
Updated:  1/11/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Randomized Trial of the Positive Action Program in Hawaii Schools
The Positive Action Program: Outcomes and Mediators
Status: Enrolling
Updated: 1/11/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Randomized Trial of the Positive Action Program in Hawaii Schools
The Positive Action Program: Outcomes and Mediators
Status: Enrolling
Updated:  1/11/2017
Oregon State University
mi
from
Corvallis, OR
Randomized Trial of the Positive Action Program in Hawaii Schools
The Positive Action Program: Outcomes and Mediators
Status: Enrolling
Updated: 1/11/2017
Oregon State University
mi
from
Corvallis, OR
Click here to add this to my saved trials
Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients.
Levetiracetam (Keppra) Tolerability and Efficacy in Cocaine Abusing Methadone-maintained Patients.
Status: Enrolling
Updated:  1/11/2017
Va Ct Healthcare System
mi
from
West Haven, CT
Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients.
Levetiracetam (Keppra) Tolerability and Efficacy in Cocaine Abusing Methadone-maintained Patients.
Status: Enrolling
Updated: 1/11/2017
Va Ct Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)
Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)
Status: Enrolling
Updated:  1/11/2017
Cincinnati Addiction Research Center
mi
from
Cincinnati, OH
Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)
Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)
Status: Enrolling
Updated: 1/11/2017
Cincinnati Addiction Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)
Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)
Status: Enrolling
Updated:  1/11/2017
Ventana Clinical Research Corporation
mi
from
Toronto,
Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)
Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)
Status: Enrolling
Updated: 1/11/2017
Ventana Clinical Research Corporation
mi
from
Toronto,
Click here to add this to my saved trials
Vigabatrin Ph 1 Cocaine Interaction Study
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Intravenous Cocaine and Oral Gamma Vinyl-Gamma-Amino Butyric Acid (VIGABATRIN) Interaction Study
Status: Enrolling
Updated:  1/11/2017
University of Texas Health Science Center
mi
from
San Antonio, TX
Vigabatrin Ph 1 Cocaine Interaction Study
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Intravenous Cocaine and Oral Gamma Vinyl-Gamma-Amino Butyric Acid (VIGABATRIN) Interaction Study
Status: Enrolling
Updated: 1/11/2017
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Buprenorphine Naltrexone-P1 A-Cocaine
Attenuation of Opioid Effects of Three Different Doses of Sublingual Buprenorphine / Naloxone by Oral Naltrexone in Healthy Volunteers
Status: Enrolling
Updated:  1/11/2017
Drug Dependence Research Center
mi
from
San Fransisco, CA
Buprenorphine Naltrexone-P1 A-Cocaine
Attenuation of Opioid Effects of Three Different Doses of Sublingual Buprenorphine / Naloxone by Oral Naltrexone in Healthy Volunteers
Status: Enrolling
Updated: 1/11/2017
Drug Dependence Research Center
mi
from
San Fransisco, CA
Click here to add this to my saved trials
Evaluating Alternative Aftercare Models for Ex-offenders
Evaluating Alternative Aftercare Models for Ex-offenders
Status: Enrolling
Updated:  1/11/2017
DePaul University
mi
from
Chicago, IL
Evaluating Alternative Aftercare Models for Ex-offenders
Evaluating Alternative Aftercare Models for Ex-offenders
Status: Enrolling
Updated: 1/11/2017
DePaul University
mi
from
Chicago, IL
Click here to add this to my saved trials
Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)
Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms and Social Dysfunction in Schizophrenia Patients
Status: Enrolling
Updated:  1/12/2017
New York State Psychiatric Institute
mi
from
New York, NY
Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)
Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms and Social Dysfunction in Schizophrenia Patients
Status: Enrolling
Updated: 1/12/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Association Between Smoking, Brain Activity, Genes, and ADHD
Smoking, Neurocircuitry and Genes in Adult ADHD
Status: Enrolling
Updated:  1/12/2017
2500 Red Hill Avenue
mi
from
Santa Ana, CA
Association Between Smoking, Brain Activity, Genes, and ADHD
Smoking, Neurocircuitry and Genes in Adult ADHD
Status: Enrolling
Updated: 1/12/2017
2500 Red Hill Avenue
mi
from
Santa Ana, CA
Click here to add this to my saved trials
N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder
Double-Blind, Placebo-Controlled Trial of N-acetylcysteine (NAC) for the Treatment of Pediatric Obsessive-Compulsive Disorder
Status: Enrolling
Updated:  1/12/2017
Yale Child Study Center
mi
from
New Haven, CT
N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder
Double-Blind, Placebo-Controlled Trial of N-acetylcysteine (NAC) for the Treatment of Pediatric Obsessive-Compulsive Disorder
Status: Enrolling
Updated: 1/12/2017
Yale Child Study Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
HCV Treatment of IDUs After Buprenorphine Stabilization
Status: Enrolling
Updated:  1/12/2017
OASIS
mi
from
Oakland, CA
Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
HCV Treatment of IDUs After Buprenorphine Stabilization
Status: Enrolling
Updated: 1/12/2017
OASIS
mi
from
Oakland, CA
Click here to add this to my saved trials
Open-label Ziprasidone Study for Psychosis Treatment in Adolescents
Open-label Feasibility Study for the Treatment of Psychotic Adolescents With Ziprasidone in the Inpatient and Day Hospital Settings
Status: Enrolling
Updated:  1/12/2017
NYSPI
mi
from
New York, NY
Open-label Ziprasidone Study for Psychosis Treatment in Adolescents
Open-label Feasibility Study for the Treatment of Psychotic Adolescents With Ziprasidone in the Inpatient and Day Hospital Settings
Status: Enrolling
Updated: 1/12/2017
NYSPI
mi
from
New York, NY
Click here to add this to my saved trials
Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies
Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies
Status: Enrolling
Updated:  1/12/2017
New York State Psychiatric Institute
mi
from
New York, NY
Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies
Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies
Status: Enrolling
Updated: 1/12/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
M-CPP and Fenfluramine in Cocaine Addicts - 3
To Study Predictive Values of M-CPP and Fenfluramine in Cocaine Addicts
Status: Enrolling
Updated:  1/17/2017
VA Medical Center
mi
from
Brooklyn, NY
M-CPP and Fenfluramine in Cocaine Addicts - 3
To Study Predictive Values of M-CPP and Fenfluramine in Cocaine Addicts
Status: Enrolling
Updated: 1/17/2017
VA Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Efficacy/Safety Trial of Buprenorphine/Nx for Opiate Dependence
Status: Enrolling
Updated:  1/17/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Efficacy/Safety Trial of Buprenorphine/Nx for Opiate Dependence
Status: Enrolling
Updated: 1/17/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Metabolic Effects of Cocaine
Elucidating the Role of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Mechanisms Underlying Cocaine Dependence
Status: Enrolling
Updated:  1/17/2017
Massachusetts General Hospital
mi
from
Boston, MA
Metabolic Effects of Cocaine
Elucidating the Role of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Mechanisms Underlying Cocaine Dependence
Status: Enrolling
Updated: 1/17/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
University of California at San Francisco
mi
from
San Francisco, CA
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
Connecticut Clinical Research
mi
from
Cromwell, CT
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
Connecticut Clinical Research
mi
from
Cromwell, CT
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
Sarkis Clinical Trials
mi
from
Gainesville, FL
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
Miami Research Associates
mi
from
South Miami, FL
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
Goldpoint Clinical Research
mi
from
Indianapolis, IN
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
Kennedy Krieger Institute
mi
from
Baltimore, MD
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
St Charles Psychiatric Associates - Midwest Research Group
mi
from
St. Charles, MO
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
St Charles Psychiatric Associates - Midwest Research Group
mi
from
St. Charles, MO
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/18/2017
Richard H. Weisler, MD, PA
mi
from
Raleigh, NC
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/18/2017
Richard H. Weisler, MD, PA
mi
from
Raleigh, NC
Click here to add this to my saved trials